Serum IDO activity was also plotted according to the COPD Global Initiative for Obstructive Lung Disease (GOLD) stage, and found to decrease with increasing disease severity (p = 0.03, Figure S4). Here, IDO1 is linked to chronic obstructive pulmonary disease.